Definitive Analysis

Financial Statements

Fundamentals

Valuations

Miscellaneous

Analysis Mode

Full Access

See Pricing Start Trial
Multiples Valuation: Haemato AG

Haemato AG (HAEK.DE)

Industry: Drug Manufacturers - Specialty & Generic Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $23.97 — $70.57
Selected (Average) $34.87
Upside to Live 62.93%
Full Range Fair Value
Range (Low - High) $27.25 — $83.78
Selected (Average) $39.08
Upside to Live 82.63%
Live Price $21.40

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
SNDL 119 SNDL Inc. 690 - - - - - -
ITCI 120 Intra-Cellular The 681 - - - - - -
002773.SZ 121 Chengdu Kanghong P 662 27.28 24.60 20.41 18.11 22.34 18.98
001630.KS 122 Chong Kun Dang Hol 644 6.41 7.07 3.44 3.12 9.92 15.04
096760.KS 123 JW Holdings Corpor 634 5.20 5.20 1.80 1.16 2.85 3.34
600750.SS 124 Jiang Zhong Pharma 624 16.43 14.70 11.39 10.28 15.80 9.64
086450.KQ 125 DongKook Pharmaceu 606 13.83 13.95 7.22 6.95 8.71 9.48
HAEK.DE 126 Haemato AG 605 12.02 12.09 5.93 5.64 5.18 5.47
2HQ.DE 127 Tilray Brands, Inc 603 - - - - 234.37 -
4547.T 128 Kissei Pharmaceuti 589 12.30 9.96 7.58 6.72 - -
000153.SZ 129 Anhui Fengyuan Pha 588 26.38 24.36 24.05 25.66 72.99 32.39
3737.HK 130 Zhongzhi Pharmaceu 575 5.35 5.63 3.02 3.04 34.73 4.78
084110.KQ 131 Huons Global Co., 559 22.93 24.49 1.93 1.55 7.83 6.36
AJANTPHARM.BO 132 Ajanta Pharma Limi 550 30.88 27.59 21.52 19.78 23.19 13.75
4559.T 133 Zeria Pharmaceutic 548 13.49 11.25 6.24 5.32 18.14 9.35
300119.SZ 134 Tianjin Ringpu Bio 548 23.00 21.55 17.13 16.00 25.56 21.21

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple13.6612.606.736.0216.979.48
Full Range Median Multiple15.1314.327.406.8320.249.64
Industry Multiple16.9615.8610.489.8139.7013.12
Market Implied Multiple11.1811.255.485.214.795.06
Company (HAEK.DE) Multiple12.0212.095.935.645.185.47
(*) Net Income / EBITDA / Revenue121222232523
Winsorized Enterprise ValueN/AN/A145137419222
Full Range Median Enterprise ValueN/AN/A160155500225
(-) Net Debt-13-13-13-13-13-13
Winsorized Equity Value160147158149432234
Full Range Median Equity Value177167172168513238
(/) Shares Outstanding666666
Winsorized Fair Value$26.13$23.97$25.82$24.40$70.57$38.31
Full Range Median Fair Value$28.95$27.25$28.18$27.42$83.78$38.92
Current Price$21.40$21.40$21.40$21.40$21.40$21.40
Upside / Downside22.12%12.02%20.63%14.02%229.75%79.02%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$18.29$16.78$18.07$17.08$49.40$26.82
Buy / Don't BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyBUYBUY